A new study conducted by researchers has found that babies whose mothers possess a higher level of particular type of vitamin B during pregnancy may be at a lesser risk of developing eczema, which involves inflammation of the skin. The study, from the University of Southampton in Britain, is the first to link maternal serum levels of nicotinamide — a naturally occurring form of vitamin B3 — and related metabolites to the risk of atopic eczema — the most common form of eczema — in the child. The results showed that offspring of mothers with higher levels of nicotinamide had a 30 per cent lower chance of developing atopic eczema at 12 months. There was an even stronger association with higher levels of anthranilic acid, a tryptophan metabolite.

No Comments

Leave a Comment